Vireo Growth (VREOF) Capital Expenditures Growth (5y) (2025 - 2026)

Vireo Growth (VREOF) Capital Expenditures Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	92.25 Bn	90.38 Bn	-
2	Teva Pharmaceutical Industries	36.58 Bn	32.83 Bn	1.97 Bn
3	Zoetis	32.71 Bn	30.77 Bn	1.62 Bn
4	Takeda Pharmaceutical	27.61 Bn	23.55 Bn	4.39 Bn
5	RedHill Biopharma	23.06 Bn	23.06 Bn	-
6	United Therapeutics	22.81 Bn	20.66 Bn	648.10 Mn
7	Viatris	20.68 Bn	18.88 Bn	1.16 Bn
8	Neurocrine Biosciences	18.35 Bn	17.03 Bn	800.70 Mn
9	Elanco Animal Health	12.70 Bn	12.28 Bn	785.00 Mn
10	Vireo Growth	10.32 Bn	10.17 Bn	59.30 Mn

Download Data